CN105636647A - 使用植物组合物和多西紫杉醇治疗前列腺癌的联合疗法 - Google Patents

使用植物组合物和多西紫杉醇治疗前列腺癌的联合疗法 Download PDF

Info

Publication number
CN105636647A
CN105636647A CN201480042054.2A CN201480042054A CN105636647A CN 105636647 A CN105636647 A CN 105636647A CN 201480042054 A CN201480042054 A CN 201480042054A CN 105636647 A CN105636647 A CN 105636647A
Authority
CN
China
Prior art keywords
prostate cancer
docetaxel
extract
administration
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201480042054.2A
Other languages
English (en)
Chinese (zh)
Inventor
詹姆士·道
杰夫·道
威廉·格威克
莉娜·格威克
玛丽安·乔丹
莱斯利·威尔逊
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genyous Biomed International Inc
Original Assignee
Genyous Biomed International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genyous Biomed International Inc filed Critical Genyous Biomed International Inc
Publication of CN105636647A publication Critical patent/CN105636647A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A61K36/074—Ganoderma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/537—Salvia (sage)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/539—Scutellaria (skullcap)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CN201480042054.2A 2013-06-03 2014-06-03 使用植物组合物和多西紫杉醇治疗前列腺癌的联合疗法 Pending CN105636647A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361830626P 2013-06-03 2013-06-03
US61/830,626 2013-06-03
PCT/US2014/040769 WO2014197519A1 (en) 2013-06-03 2014-06-03 Combination therapy for prostate cancer using botanical compositions and docetaxel

Publications (1)

Publication Number Publication Date
CN105636647A true CN105636647A (zh) 2016-06-01

Family

ID=52008544

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201480042054.2A Pending CN105636647A (zh) 2013-06-03 2014-06-03 使用植物组合物和多西紫杉醇治疗前列腺癌的联合疗法

Country Status (7)

Country Link
US (1) US20160143971A1 (https=)
EP (1) EP3003490B1 (https=)
JP (1) JP2016523849A (https=)
CN (1) CN105636647A (https=)
CA (1) CA2951110A1 (https=)
SG (1) SG11201510802QA (https=)
WO (1) WO2014197519A1 (https=)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108836994A (zh) * 2018-07-25 2018-11-20 南京林业大学 一种人工林树皮皂苷类活性成分的提取方法
CN117064899A (zh) * 2023-10-13 2023-11-17 暨南大学附属第一医院（广州华侨医院） 灵芝酸a在制备治疗去势抵抗性前列腺癌的药物中的应用

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018217237A1 (en) * 2017-05-26 2018-11-29 Genyous Biomed International Combination therapy for cancer using botanical compositions and enzalutamide
US10835538B2 (en) * 2018-03-28 2020-11-17 Nymox Corporation Method of treating benign prostatic hyperlasia with antibiotics
AR133093A1 (es) * 2023-06-30 2025-08-27 Future Biome Corp Mezclas de polisacáridos de ganoderma sessile, composiciones y métodos relacionados

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050196409A1 (en) * 2003-09-24 2005-09-08 James Dao Compositions of botanical extracts for treating malignancy-associated changes
CN1878471A (zh) * 2003-09-22 2006-12-13 盖尼奥斯生物医学国际公司 用于癌症治疗的沙棘组合物
WO2012061790A1 (en) * 2010-11-04 2012-05-10 Genyous Biomed International Combination therapy for prostate cancer using botanical compositions and bicalutamide

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6395770B1 (en) * 1995-10-26 2002-05-28 Baker Norton Pharmaceuticals, Inc. Method and compositions for administering taxanes orally to human patients
US5910308A (en) 1997-03-19 1999-06-08 Sante International Inc. Herbal extract composition containing gynostemma pentaphyllum, crataegus pinnatifida and camellia sinensis
US6168795B1 (en) 1998-06-09 2001-01-02 Sant{acute over (e)} International Inc. Method for anticancer therapy using an herbal extract composition
PL1663103T3 (pl) 2003-09-08 2012-05-31 Genyous Biomed Int Inc Kompozycje roślinnych ekstraktów do leczenia nowotworu
US20110117121A1 (en) * 2006-10-27 2011-05-19 James Dao Compositions for treatment and inhibition of pain

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1878471A (zh) * 2003-09-22 2006-12-13 盖尼奥斯生物医学国际公司 用于癌症治疗的沙棘组合物
US20050196409A1 (en) * 2003-09-24 2005-09-08 James Dao Compositions of botanical extracts for treating malignancy-associated changes
WO2012061790A1 (en) * 2010-11-04 2012-05-10 Genyous Biomed International Combination therapy for prostate cancer using botanical compositions and bicalutamide

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
REBEKAH A.ET AL.,: "Genistein combined polysaccharide enhances activity of docetaxel, bicalutamide and Src kinase inhibition in androgen-dependent and independent prostate cancer cell lines", 《BJU INTERNATIONAL》 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108836994A (zh) * 2018-07-25 2018-11-20 南京林业大学 一种人工林树皮皂苷类活性成分的提取方法
CN117064899A (zh) * 2023-10-13 2023-11-17 暨南大学附属第一医院（广州华侨医院） 灵芝酸a在制备治疗去势抵抗性前列腺癌的药物中的应用
CN117064899B (zh) * 2023-10-13 2024-01-23 暨南大学附属第一医院（广州华侨医院） 灵芝酸a在制备治疗去势抵抗性前列腺癌的药物中的应用

Also Published As

Publication number Publication date
JP2016523849A (ja) 2016-08-12
US20160143971A1 (en) 2016-05-26
WO2014197519A1 (en) 2014-12-11
EP3003490A1 (en) 2016-04-13
EP3003490A4 (en) 2017-01-25
EP3003490B1 (en) 2019-11-13
CA2951110A1 (en) 2014-12-11
SG11201510802QA (en) 2016-02-26

Similar Documents

Publication Publication Date Title
JP5300195B2 (ja) 癌治療のための植物性薬品抽出物の組成物
CN103327994B (zh) 一种组合物在制备用于治疗或降低受试者体内的前列腺癌的严重性的药物中的应用
US20110293753A1 (en) Tocotrienol Compositions
Aqil et al. Anticancer phytocompounds: experimental and clinical updates
EP3630090A1 (en) Combination therapy for cancer using botanical compositions and enzalutamide
CN105636647A (zh) 使用植物组合物和多西紫杉醇治疗前列腺癌的联合疗法
US20050214394A1 (en) Hippophae rhamnoides compositions for cancer therapy
KR20110100329A (ko) 신생혈관형성 억제용 한약 조성물
KR20240020687A (ko) 암의 예방 또는 치료를 위한 혼합 생약 추출물 및 도세탁셀의병용 요법
Elsayed et al. A comprehensive review of promising phytoconstituents as anti-cancer agents: Biological mechanisms and applications across different cancers
CN101167787A (zh) 抑制血管生成的合欢属植物提取物的组合物及其制备和应用
US20150265669A1 (en) Methods and compositions for inhibiting cancer cell growth
CN105596889A (zh) 一种含白藜芦醇的抗肿瘤组合物及制备方法
Zhou et al. Natural product-induced apoptosis in oral squamous cell carcinoma via targeting mitochondrial multifunctionality
JP2017119677A (ja) 肺癌の治療に用いられる医薬組成物
Panneerselvan et al. T Potential of Herbal Medicines mmmS
HK1096855A (en) Compositions of botanical extracts for cancer therapy
HK1097420A (en) Hippophae rhamnoides compositions for cancer therapy

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20160601